Relapsed or refractory B cell acute lymphoblastic leukemia
Clinical trials for Relapsed or refractory B cell acute lymphoblastic leukemia explained in plain language.
Never miss a new study
Get alerted when new Relapsed or refractory B cell acute lymphoblastic leukemia trials appear
Sign up with your email to follow new studies for Relapsed or refractory B cell acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Cure Recruiting nowThis early-stage trial is testing an investigational therapy called B019, which uses a patient's own immune cells engineered to recognize and attack leukemia cells. The study focuses on people with B-cell acute lymphoblastic leukemia that has returned or not responded to standard…
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1 • Sponsor: Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. • Aim: Cure
Last updated Aug 19, 2026 00:00 UTC
-
Engineered immune cells take on childhood blood cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing a new CAR T-cell therapy called AUTO1 (obe-cel) in up to 30 children with B-cell acute lymphoblastic leukemia or B-cell non-Hodgkin lymphoma that has returned or not responded to treatment. The therapy uses the child's own immune cells, which are…
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat childhood leukemia
Disease control Recruiting nowThis trial investigates a personalized cell therapy called CAR-T for children and young adults (ages 5–50) with B-cell acute lymphoblastic leukemia that has relapsed or not responded to standard treatment. The therapy involves collecting a patient's own immune cells, engineering …
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Early phase 1 • Sponsor: Dr. Zaineb Akram • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC